Theratechnologies Inc T.TH

Nomination

[palinc2000]

I hereby nominate Spceo1 and Wino as representatives pf posters on this MB to ask questions during the Theratech 's CC s 
All those in favor please vote

PS Of course I presume that both nominees are willing to act on our behalf

[Wino115]

They've never let anyone other than sell-side analysts ask questions. I don't think that will change anytime soon and seems to be standard now given some of the crazy histrionics past calls on other controversial stocks had. I guess the lawyers have just decided it's better to shut it off for the general public. Only guys like Cytodyn let anyone ask a question, but that's because

[palinc2000]

Questions from investors are frequently allowed during Investors Day and it seems to me that having a representative of a Fund holding more than 6 million shares and an investor with your background  would  help not only other investors but also the Company....They could make whatever rules they want

[scarlet1967]

What CYDY is doing is working anyway I am going to schedule a call with Leah discussing their marketing and communication strategies. I won't discuss the deal as they did give their rationale justifying it earlier and I don't think she will be adding anything meaningful re the deal. I just want to see how open they are to approach a more retail friendly approach.

[palinc2000]

Quaterly CCs s should last more than a few minutes ...Having 2  uninterested sell side analysts mostly asking one or two questions benefit no one..  

[SPCEO1]

Thanks for the nomination Palin but since I am still not to the last stage of grief, I would likely only cause a unhealthy disturbance if I were granted the opportunity to ask questions, which will never happen for any of us anyway. It is quite unfortunate that the analyst coverage on THTX is so weak and, even worse, is getting weaker. Given the phase III NASH and now Fasat Tracked phase I cancer

[Wino115]

Completely agree on the analyst front. For 12 months we've all spoken about building a new audience for this new development phase. It's now somehow smaller despite opening up two large therepeutic areas both with more promise than the average entrant. It shows how competitive it is to catch the ear of qualified and credible investors, whether retail or institutional. Something has to

[scarlet1967]

I think we all need to move on from the grief stage and try to address the real issues which has been haunting the company for years.It will be helpful if they recognize the problems and try to solve it , unless few reputable analysts start covering the stock with large amount of clients any upgrades from legacy analysts won't move the needle as they havd small followers. The company obviously

[scarlet1967]

My call is scheduled for Monday 1 pm ET.

[Wino115]

I would love to do that and suggested that to them when some of the sell siders dropped out. It seems to me that if you can have a dozen or so verified institutional holders, let them ask Q's too.  I wouldn't be, but I have friends that would be and SPCEO sure would be.  They used to allow buy-siders to ask questions, but a few angry and disruptive ones ruined it for everyone.

[scarlet1967]

CYDY let investors submit questions online so abusive comments won't be addressed and I agree the CC whether related to earnings or material events would be much more informative if they spend some time answering retail investors questions. 

[jfm1330]

So Cytodyn is now the model company to emulate??? My god.... PTSD is strong here.

[scarlet1967]

I won't class it as PTSD and I am not suggesting they should do exactly what CYDY is doing! I am simply trying to bring to their attention while they are trying to convince institutions use some of the tools that CYDY and the likes have been successfully tested to reach out to the powerful retail investors which have been totally ignored by the company.

[jfm1330]

Come on! They just got fast track for oncology. This is a validation of the seriousness and importance of this program by the FDA. It was on the radar screen of every serious biopharma investor yesterday, and look the reaction today. I am doing a lot of reading since yesterday to better understand the challenges of PDCs and ADCs, since they are often compared. Again, before data on humans, a lot

[scarlet1967]

I am already COVID fatigue and thera fatigue please don't add to the list Jim fatigue. Trying to be funny....

[ANALIAS00]

That would be about time. Yes I agree.